Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Sufentanil

NCT04959812 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04959812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Sufentanil
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
March 1, 2022
Completion date
September 8, 2023
Enrollment
46 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy